Lively Biotech has obtained optimistic suggestions from regulators on a protocol modification to its ongoing proof-of-concept scientific trial evaluating tasquinimod in sufferers with myelofibrosis, a...
The U.S. Meals and Drug Administration (FDA) has accepted PD-L1 IHC 22C3 pharmDx, Code SK006, as a companion diagnostic to assist establish sufferers with epithelial...
Please guarantee Javascript is enabled for functions ofweb site accessibilityRhode Island lady, 13, beats leukemia, celebrates at Hasbro Kids's HospitalTue, 02 Jul 2024...
From left: JORGE CALIL and JESSICA MACINTYRE, D.N.P., MBA, APRN, AOCNP PHOTOS BY LOCKINVAR DENISAlong with being an all-around great nurse practitioner for...